These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3730164)

  • 1. Preliminary report on complement activating potential of polycarbonate membrane.
    Henderson LW; Chenoweth DE; Shinaberger JH; Miller J; Konstantin P
    Blood Purif; 1986; 4(1-3):74-81. PubMed ID: 3730164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study.
    Danielson BG; Hällgren R; Venge P
    Blood Purif; 1986; 4(1-3):147-50. PubMed ID: 3524607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility and hemodynamic studies during polycarbonate versus cuprophane membrane dialysis.
    Schohn DC; Jahn HA; Eber M; Hauptmann G
    Blood Purif; 1986; 4(1-3):102-11. PubMed ID: 3730154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polycarbonate hemodialysis membrane: neutrophil, platelet, complement and chemiluminescence kinetics during first and second use.
    Heierli C; Markert M; Frei J; Lambert PH; Wauters JP
    Blood Purif; 1986; 4(1-3):82-7. PubMed ID: 3730165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes.
    Hörl WH; Riegel W; Schollmeyer P
    Nephron; 1987; 45(4):272-6. PubMed ID: 3035392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility of a polycarbonate membrane. A preliminary report.
    De Broe ME; van Waeleghem JP; Heyrman R; De Backer W
    Blood Purif; 1986; 4(1-3):168-71. PubMed ID: 3015165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers.
    Chenoweth DE; Henderson LW
    Artif Organs; 1987 Apr; 11(2):155-62. PubMed ID: 3496072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and tolerance of a new polycarbonate membrane in elderly patients. Preliminary results.
    Forêt M; Hachache T; Alibeu C; Kuentz F; Meftahi H
    Blood Purif; 1986; 4(1-3):159-67. PubMed ID: 3488067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodialysis-induced activation of complement. Effects of different membranes.
    Levett DL; Woffindin C; Bird AG; Hoenich NA; Ward MK; Kerr DN
    Blood Purif; 1986; 4(4):185-93. PubMed ID: 3790264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte activation during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
    Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility of a new polycarbonate dialysis membrane.
    Knudsen F; Nielsen AH; Pedersen JO; Grunnet N; Jersild C
    Blood Purif; 1986; 4(1-3):142-6. PubMed ID: 2942156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
    Chenoweth DE
    Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.